Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Arboretum LifeSciences raises $30M in Series A funding to enhance scientific infrastructure and accelerate genetic testing adoption.
Amount Raised
$30 Million
Round Type
Series A
Investors
Description
Arboretum LifeSciences, based in Cambridge, MA, raised $30M in Series A financing. The funding will be used to build scientific and operational infrastructure, expand product development, and scale its molecular research network. Backers included F-Prime, GV, and .406 Ventures. The company focuses on integrating AI with genetic testing for common diseases.
Fundz sees it the moment Arboretum LifeSciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansArboretum LifeSciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.